Who is sponsoring NCT04566042?

NCT04566042 is sponsored by Swansea University.

What drugs are being tested in NCT04566042?

Interventions in NCT04566042: Acceptance and commitment therapy video game.

What condition does NCT04566042 study?

NCT04566042 studies Depression, Anxiety, Stress, Emotional, Quality of Life, Psychological Flexibility, Social Connecedness.

Is NCT04566042 still recruiting?

NCT04566042 is currently completed. Last updated 4 March 2024.

Last reviewed 2024-03-04 · How we verify

NCT04566042

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Novel ACT-based Video Game

Completed NA Last updated 4 March 2024

What this trial tests

NA trial testing Acceptance and commitment therapy video game in Depression in 29 participants. Completed in 31 December 2022.

Timeline

31 July 2021

Primary endpoint
31 January 2022

31 December 2022

Quick facts

Lead sponsor	Swansea University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	29
Start date	31 July 2021
Primary completion	31 January 2022
Estimated completion	31 December 2022
Sites	1 location across United Kingdom

Drugs / interventions tested

Acceptance and commitment therapy video game

Conditions studied

Depression — all drugs for Depression →
Anxiety — all drugs for Anxiety →
Stress, Emotional — all drugs for Stress, Emotional →
Quality of Life — all drugs for Quality of Life →

Sponsor

Swansea University

Who can join

18 and older, any sex, with Depression or Anxiety. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A feasibility study to explore whether an acceptance and commitment therapy (ACT) can reduce mental health outcomes (stress, anxiety, depression) and increase psychological flexibility.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

A novel ACT-based video game to support mental health through embedded learning: a mixed-methods feasibility study protocol.
Edwards DJ, Kemp AH. · · 2020 · cited 4× · PMID 33199427 · DOI 10.1136/bmjopen-2020-041667
Mixed-methods feasibility outcomes for a novel ACT-based video game 'ACTing Minds' to support mental health.
Gordon TC, Kemp AH, Edwards DJ. · · 2024 · cited 1× · PMID 38553053 · DOI 10.1136/bmjopen-2023-080972

Verify or expand the search:

Other recruiting trials for Depression

Currently open trials in the same condition.

NCT07336238 — Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or · Phase 2 · recruiting
NCT06906939 — A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression · EARLY_PHASE1 · recruiting
NCT07517549 — Sexual Health Education During Pregnancy · NA · recruiting
NCT06408246 — ACE-D Aim 3 Clinical Cognitive Trial to Enhance Translation in Depression · Phase 2 · recruiting
NCT07449676 — Effects of an Innovative TCM-based Tui Jing Therapy on Psychological and Neurophysiological Functions in Depression · NA · recruiting

Other Swansea University trials

Trials by the same sponsor.

NCT07452562 — Hesperidin RCT in MS · NA · recruiting
NCT07272096 — ACTing Minds: An ACT-based Videogame for Mental Health · NA · completed
NCT06961513 — Patient Evaluation of Treatment of Pelvic-floor Muscle Dysfunction. · not yet recruiting
NCT06698588 — Symptom-specific Effects of Omega-3 Across Neurodevelopmental Symptoms · NA · recruiting
NCT06407557 — Optimizing Older Adults' Home Space for Physical Activity · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04566042 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Swansea University
Last refreshed: 4 March 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04566042.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing